Showing results (11-20 of 179) with videos related to
Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2009
Identification of CCR4 and other essential thyroid hormone receptor co-activators by modified yeast synthetic genetic array analysisManjapra Govindan, Xianwang Meng, Clyde L Denis, et al.Molecular and Cellular Endocrinology|October 22, 2008
Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell linesVanya Shah, Phuong Nguyen, Ngoc-Ha Nguyen, et al.Journal of Medicinal Chemistry|July 12, 2002
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitmentNgoc-Ha Nguyen, James W Apriletti, Suzana T Cunha Lima, et al.Nuclear Receptor Signaling|November 8, 2006
Corepressor/coactivator paradox: potential constitutive coactivation by corepressor splice variantsXianwang Meng, Vishnuka D Arulsundaram, Ahmed F Yousef, et al.Nuclear Receptor|August 9, 2003
ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminusPaul Webb, Cathleen Valentine, Phuong Nguyen, et al.Endocrinology|November 10, 2011
Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1Chaoshen Yuan, Jean Z H Lin, Douglas H Sieglaff, et al.Endocrinology|October 23, 2012
Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptorJean Z Lin, Alexandro J Martagón, Willa A Hsueh, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2005
E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor modeXianwang Meng, Paul Webb, Yong-Fan Yang, et al.The Journal of General Virology|October 19, 2013
The adenovirus 55 residue E1A protein is a transcriptional activator and binds the unliganded thyroid hormone receptorVishnuka D Arulsundaram, Paul Webb, Ahmed F Yousef, et al.AIDS Patient Care and Stds|April 22, 2008
Protease inhibitor resistance update: where are we now?Rose Kim, John D BaxterPageof 18